Chicago Capital Management, LLC Vectiv Bio Holding Ag Call Options Transaction History

Chicago Capital Management, LLC

  • $40 Million
  • Q3 2024

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

Others Institutions Holding VECT

# of Institutions
1
Shares Held
510K
Call Options Held
0
Put Options Held
0
View Full List

About VectivBio Holding AG

VECT Quotes by TradingView
  • Ticker VECT
  • Exchange NASDAQ
  • Description
  • VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for treatments of severe rare conditions. It develops apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 that is in Phase III clinical trial for the treatment of patients with sho...
More about VECT
Track This Portfolio

Track Chicago Capital Management, LLC Portfolio

Follow Chicago Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email